Georg Schmidt has a diverse background in project management within the biopharmaceutical industry. Georg has held various leadership positions at companies such as CureVac, Takeda, and Rentschler Biopharma SE. Georg has experience in overseeing drug development projects, managing cross-functional teams, and implementing project management standards. With a strong educational background in Biology, including a PhD, Georg has successfully led teams and projects in areas of infectious diseases, vaccine operations, and global manufacturing and supply chain.
October 1, 2023 - present
January, 2024
October, 2022
March, 2021